Page 282 - PROGRAMME2018

P-504 Long term cumulative rate of use of frozen sperm in cancer patients.
M. Reschini1, S. Ferrari1, C. Guarneri1, S. Noli2, A. Paffoni3, E. Somigliana2
1Fondazione Ca' Granda Ospedale Maggiore Policlinico, Infertility Unit, Milano, Italy
2Università degli Studi di Milano, Department of Clinical Sciences and Community Health, Milano, Italy 3ASST Lariana, Infertility Unit, Cantù, Italy
P-505 Comparison of conventional and random start ovarian stimulation for fertility preservation in oncological patients
N. Jancar1, E. Vrtacnik Bokal1, I. Virant Klun1, M. Stimpfel1, L. Bacer Kermavner1, V. Salamun1
1University Medical Center Ljubljana, Department of Human Reproduction- Division of Obstetrics and Gynecology, Ljubljana, Slovenia
P-506 Does oxygen tension influence in vitro maturation of human oocytes in a fertility preservation program? Preliminary results of a prospective auto-controlled study.
M. Dahoun1, C. Herbemont1, N. Sermondade1, A. Seroka2, B. Dagher-Hayeck2, M. Comtet2, C. Vinolas2, I. Cedrin-Durnerin2, M. Grynberg2, C. Sifer1
1Hôpital Jean Verdier, Histologie-Embryologie-Cytogénétique-CECOS, bondy, France 2Hôpital Jean Verdier, Médecine de la reproduction, bondy, France
P-507 Spermatogonial quantities in untreated prepubertal cancer patients are comparable to normative prepubertal spermatogonial values
I. Masliukaite1, E. Ntemou2, M. Van de Wetering3, A. Meißner1, L. Kremer3, S. Repping1, K. Jahnukainen4,5, E. Goossens2, A. Van Pelt1
1Academic Medical Center AMC, Center for Reproductive Medicine, Amsterdam, The Netherlands
2Vrije Universiteit Brussel VUB, Biology of the Testis- Department of Reproduction- Genetics and Regenerative Medicine, Brussels, Belgium
3Academic Medical Center AMC, Department of Pediatric Oncology- Emma Children's Hospital, Amsterdam, The Netherlands
4Karolinska Institutet and University Hospital, Department of Women’s and Children’s Health- Pediatric Endocrinology Unit, Stockholm, Sweden
5University of Helsinki and Helsinki University Central Hospital, Children´s Hospital, Helsinki, Finland
P-508 New miRNAs to evaluate ovarian reserve in patients with breast cancer
S. El Moghrabi1, C. Decanter2, P. Pigny3, D. Haouzi1, S. Hamamah4
1Inserm U1203, Institut de Médecine Régénérative et Biothérapies IRMB- Hôpital Saint Eloi- CHU Montpellier, Montpellier, France
2Service d'Assistance Médicale à la Procréation et de préservation de la fertilité- Hôpital Jeanne de Flandre- CHRU Lille, EA 4308 Gamétogénèse et qualité du gamète- Centre Hospitalier Universitaire de Lille, Lille, France
3Laboratoire de Biochimie Hormonologie HMNO- Centre de Biologie Pathologie- CHRU Lille, Inserm- UMR-S 1172, Lille, France
4Service de Biologie de la Reproduction- Hôpital Arnaud de Villeneuve- CHU Montpellier, ART/PGD Department, Montpellier, France
282